Search Results

View all available languages for this measure. BACK FAIT-F Languages English German

Download this measure in English. BACK peds FAACT English Downloads Download PDF - Child Download DOC - Child Download PDF - Parent of Child Download DOC - Parent of Child Download PDF - Adolescent Download DOC - Adolescent Download PDF - Parent of Adolescent Download DOC - Parent of Adolescent

Over 25 years of methodologically rigorous COA translations. FACITtrans History V2 OVER 25 YEARS OF METHODOLOGICALLY RIGOROUS COA TRANSLATIONS Today 2024 2023 2022 2021 ISO 2021 2020 ISO 2017 2016 2012 2009 2005 2004 2001 1996 1994 Today 2024 Today Deep scientific roots and cutting edge knowledge Quality and processes are our strength. Flexible, creative solutions are our calling card. As contributors to the ISOQOL AI in COA translation guidance , numerous publications and developers of AI translation quality assessment tools, we are uniquely placed in the crossroads of technological advances and scientific rigor. While most of our work is for the pharmaceutical industry, we regularly partner with leading academic research groups including the Medical Social Services program at Northwestern University which was founded by our very own Dr. Cella. 2023 2024 Reinforcing our global reach Vendor management expansion to meet demand and reinforce our global reach throughout Africa, India, LATAM, US, and Europe for translation, embedded interviews and more. 2022 2023 Savic L., Arnold B., Baily A., Mackey DJ., Olaiya P. Translation and Linguistic Validation of the EXACT for Use with COPD Patients in African Countries. Presented at ISOQOL Calgary, October 2023. ISOQOL poster of the year Embedded Interviews (native language during clinical trials) become a fixed part of our growing service offerings. Not only do we carry out the interviews, but we transcribe and translate them. Clients love our openness to new areas and our constant eye on quality and processes in any area we enter. 2022 Embedded and exit clinical trial interview services 2021 2022 European team expansion to meet increased demand 2021 C-Path selects FACITtrans as their preferred translation vendor. 2021-2023 Thought Leadership in Action Our Executive Director, Emily Parks-Vernizzi, served as ISOQOL’s TCA-SIG Co-Chair and is currently a member of the TCA-SIG Steering Committee and the Digital Health and eCOA SIG ISO 2021 I SO 2021 FACITtrans Earns ISO 17100:2015 Certification Building from our ISO 9001:2015 certification, we placed our translation and processes under additional scrutiny to earn our ISO 17100:2015 certification, further reinforcing our commitment to the patients’ voice through our high-quality COA translation and linguistic validation. We are proud to receive significant auditor praise for our processes at every surveillance and recertification. 2020 2020 JPRO Paper of the Year Our president, Benjamin Arnold, co-authors JPRO paper of the year, “Good practices for the translation, cultural adaptation, and linguistic validation of clinician-reported outcome, observer-reported outcome, and performance outcome measures”. Soon after publication, the FDA cites this article in their guidance to help clinical trial sponsors select, use, and optimize clinical outcome assessments (COAs) in their trials. McKown S, Acquadro C, Anfray C, Arnold B , Eremenco S, Giroudet C, Martin M, Weiss D. Good practices for the translation, cultural adaptation, and linguistic validation of clinician-reported outcome, observer-reported outcome, and performance outcome measures. J Patient Rep Outcomes 4 , 89 (2020). https://doi.org/10.1186/s41687-020-00248-z ISO 2017 I SO 2017 FACITtrans Earns ISO 9001:2015 Certification Quality processes have always been central to our work, which is why our group co-authored the 2005 ISPOR translations guidelines. Our ISO 9001:2015 certification in quality management underscores our commitment to our clients and research collaborators. 2016 2016-2018 Thought Leadership in Action Our President, Benjamin Arnold, served as ISOQOL’s Translation and Cross-Cultural Adaptation - Special Interest Group (TCA-SIG) Co-Chair, and is currently a member of the TCA-SIG Steering Committee. 2012 2012 eCOA Early Adapters The FACIT measurement system is a forerunner of eCOA adaptation/localization. FACIT Group establishes close ties with leading eCOA developers. 2009 2005 2009 FACITtrans is born. The translation and formatting team formerly part of CORE becomes FACITtrans, a boutique language service provider under the scientific direction of Dr. Cella, with close connections to the outcomes scientists at Northwestern’s Department of Medical Social Sciences. 2004 2005 Industry Cornerstone Our translation group co-authors the landmark ISPOR translation and cultural adaptation guidelines that are now accepted as industry standard. Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A. and Erikson, P. (2005), Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation. Value in Health, 8: 94-104. 2001 2004 Leading the Way with PROMIS FACITtrans develops first-ever PROMIS translations into Spanish and authors the definitive concept definitions for PROMIS. Arnold B., Correia H., Cella D. Translation of the Patient Reported Outcomes Measurement Information System into Spanish. Poster presentation at the 14th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, FL, 2009. 1996 2001 The translation group publishes an article, and causes a stir. The translation group publishes the first-ever article to promote the universal approach to COA translation, which 20 years later is still considered methodologically novel. Eremenco S., Arnold B., Cella D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. 1994 Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. 1996 The FACIT Translation Methodology is official. 1994 Clinicians request the FACT-G in Spanish. Our translation group is born, with equivalence and quality at the forefront of our work. Meet the Team Benjamin Arnold, MA President Emily Parks-Vernizzi, MBA Executive Director MEET THE WHOLE TEAM FACITtrans is ISO 9001:2015 and ISO 17100:2015 certified.

View all available languages for this measure. BACK NFBlSI-18 Languages Afrikaans Arabic Bengali Bulgarian Chinese - Simplified Chinese - Traditional Croatian Czech Danish Dutch English Estonian Finnish French German Greek Gujarati Hebrew Hindi Hungarian Italian Japanese Kannada Korean Latvian Lithuanian Malayalam Marathi Norwegian Polish Portuguese Punjabi Romanian Russian Serbian Sesotho Slovak Slovene Spanish Swedish Tamil Telugu Thai Turkish Xhosa Zulu

Download scoring documents for this measure. BACK PRRS Scoring Downloads Download PDF

The Functional Assessment of Chronic Illness Therapy System of Quality of Life questionnaires and all related subscales, translations, and adaptations (“FACIT System”) are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Copyright / Terms of Use Copyright The Functional Assessment of Chronic Illness Therapy System of Quality of Life questionnaires and all related subscales, translations, and adaptations (“FACIT System”) are owned and copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System resides strictly with Dr. Cella. Dr. Cella has granted FACIT.org (We/Us) the right to license usage of the FACIT System to other parties. Terms of Use For purposes of reviewing and learning about the FACIT measurement system, users may access and download English versions of FACIT measures and items from this website. You may also request access to translated versions by registering on the site and requesting them. However, in order to use any of our measures, permission must first be obtained by registering and obtaining a license. You can research our measures here : Once you have determined which questionnaire is best for your research question or population, you will need to register in order to either request translated versions and/or request a license-for-use. Answers to other questions can be found in our FAQ section. Use of any FACIT measure without licensed permission constitutes a violation of copyright law. The following terms are applicable to all our licenses. Other terms also apply: If you receive a translation at no cost (e.g., if you represent a non-profit organization or hospital), you may not earn or enable any financial gain through the distribution, re-use, marketing, or transfer of the licensed material. You agree that the use or implementation of the FACIT system (including any resulting data) under your license will not be used in any commercial activity and will not benefit any party via any financial transaction. You may not modify any part of the FACIT System without expressed permission from FACIT.org. You may not translate any part of the FACIT System without expressed permission from FACIT.org. In any publication that references the FACIT System and on every element of the FACIT System used in data collection, any copyright information will be listed as it appears on the questionnaire itself. If the FACIT System is made available on the Internet, one of the following security measures must be implemented to ensure controlled access: (1) password-protected access: all users must be required to enter a valid, individualized password; (2) restricted link or access code: alternatively, access to the FACIT System may be granted through a special link or access code, which must be securely distributed and controlled by Licensee. We ask that you provide us with copies of any publications resulting from your study or produced as a result of collecting data with any FACIT questionnaire. Due to the ongoing and evolving nature of questionnaire development, treatment modalities, and cross-cultural linguistic research, FACIT.org reserves the right to make adaptations or revisions to wording in the FACIT System. If such changes occur while your license is in force, you will have the option to use the changed or unchanged version. FACIT.org reserves the right to withdraw any license if the licensee engages in scientific or copyright misuse of the FACIT system of questionnaires.

Download this measure in English. BACK FACT-Leu English Downloads Download PDF Download DOC

View all available languages for this measure. BACK OMDQ Languages English

FACT-Bl-Cys Functional Assessment of Cancer Therapy – Bladder – Cystectomy For patients undergoing cystectomy (formerly FACT-VCI) LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview The Functional Assessment of Cancer Therapy – Bladder – Cystectomy (FACT-Bl-Cys), originally developed as the FACT – Vanderbilt Cystectomy Index (FACT-VCI), is a condition-specific instrument for patients undergoing radical cystectomy (RC) and urinary diversion (UD) for bladder cancer that measures five domains: Physical, social, emotional, functional well-being, and a bladder/cystectomy subscale. The initial draft was administered to patients with bladder cancer undergoing RC and UD at two major cancer centers. Statistical methods included principal components analysis, Cronbach’s coefficient alpha, and nonparametric correlation coefficients. The FACT-G was used to test criterion-related validity and a linear mixed model tested the effects of time and diversion type on longitudinal scores. The bladder/cystectomy subscale produced a reliable and valid summary score for bladder cancer patients undergoing RC and UD. MEASURE NAME: Functional Assessment of Cancer Therapy – Bladder – Cystectomy (FACT-Bl-Cys) VERSION: 4 NUMBER OF ITEMS: 44 PATIENT POPULATION: Bladder cancer patients 18 years and older undergoing radical cystectomy and urinary diversion RECALL PERIOD: Past 7 days RESPONSE SCALE: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being, Bladder/Cystectomy Subscale TIME FOR COMPLETION: 10-15 minutes SCORING: Manual scoring template, some items are reverse scored. Subscale scores and total scores possible. RELATED MEASURES: FACT-Bl , FBlSI , NCCN/FACT FBlSI-18 DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FACT-Bl-Cys can be obtained by registering for permission. Users are not permitted to translate the FACT-Bl-Cys without permission from FACIT.org. Permission from FACIT.org to translate the FACT-Bl-Cys may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Anderson C.B., Feurer I.D., Large M.C., Steinberg G. D., Barocas D.A., Cookson M.S., Penson D.F. Pychometric characteristics of a condition-specific health-related quality-of-life survey: The FACT-Vanderbilt Cystectomy Index. Urology; 80(1): 77-83. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FACT-Bl Functional Assessment of Cancer Therapy – Bladder LEARN MORE FBlSI Functional Assessment of Cancer Therapy Bladder Cancer Symptom Index - 7 Item Version LEARN MORE NCCN-FACT FBlSI-18 NCCN/FACT Bladder Symptom Index LEARN MORE

Download scoring documents for this measure. BACK FACT-Taxane Scoring Downloads Download DOC

FLSI Functional Assessment of Cancer Therapy Lung Cancer Symptom Index - 6 Item Version For patients with Lung cancer; A FACT-Lung Symptom Index (a subset of FACT-L containing 6 items) LICENSE THIS MEASURE Overview Language Availability Licensing Selected References Related Measures Overview Overview Below are the details for the FLSI measure: MEASURE NAME: Functional Assessment of Cancer Therapy Lung Cancer Symptom Index - 6 Item Version (FLSI) VERSION: 4 NUMBER OF ITEMS: 6 PATIENT POPULATION: Lung cancer patients 18 years and older RECALL PERIOD: Past 7 days RESPONSE SCALE: Response scale: 5 point Likert-type scale DATA COLLECTION: Paper and electronic ADMINISTRATION: Self-administration and interview when applicable SUBSCALE DOMAINS: Lung cancer symptom index TIME FOR COMPLETION: Less than 5 minutes SCORING: Manual scoring template, some items are reverse scored. Total scores available. SAS/SPSS algorithms available. RELATED MEASURES: FACT-L , NFLSI-17 , FLSI-12 , FACT-PSI , FACT-LCS DOWNLOAD MEASURE IN ENGLISH DOWNLOAD SCORING DOCUMENT Language Availability Available translations of the FLSI can be obtained by registering for permission. Users are not permitted to translate the FLSI without permission from FACIT.org. Permission from FACIT.org to translate the FLSI may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators, QA steps and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor to translate the FACIT measurement system. Please contact us for more information. VIEW AVAILABLE LANGUAGES Language Availability Licensing Licensing Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained. Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use. To license an available version of this measure for commercial or non-commercial use, please complete our registration form . All of the information provided in the form will be kept strictly confidential. For questions, please contact us . LICENSE THIS MEASURE Selected References Selected References Cella, D., Paul, D., Yount, S., Winn, R., Chang, C-H, Banik, D., & Weeks, J. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Investigation 2003; 21(4): 526-535. doi: 10.108/CNV-120022366. Cella, D., Rosenbloom, S., Beaumont, J., Yount, J., Paul, D., Hampton, D., Abernethy, A., Jacobsen, P., Syrjala, K., & Von Roenn, J. Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer. Journal of the National Comprehensive Cancer Network; 2011; 9(3): 268-278. doi: 10.6004/jnccn.2011.0026. Bonomi, A.E., Cella, D.D., Hahn, E.A., Bjordal, K., Sperner, B., Gangeri, L., Bergman, B., Willems, J., Hanquet, P., & Zittoun, R. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 1996; 5: 309-320. Eremenco, S., Arnold, B., Cella, D. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 2005; 28(2): 212-232. Webster K., Cella D., Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: Properties applications, and interpretation. Health and Quality of Life Outcomes 2003; 1(1): 79-85. Yost K.J., Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences: The FACIT experience. Evaluation & the Health Professions 2005; 28(2): 172-191. LICENSE THIS MEASURE Related Measures Related Measures FACT-L Functional Assessment of Cancer Therapy – Lung LEARN MORE NFLSI-17 National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Lung Cancer Symptom Index - 17 Item Version LEARN MORE FLSI-12 Functional Assessment of Cancer Therapy Lung Cancer Symptom Index - 12 Item Version LEARN MORE

View all available languages for this measure. BACK PROMIS Pool v1.0 - Dyspnea Airborne Exposure Languages English